Sino Medical Sciences Stock Fundamentals
| 688108 Stock | 10.25 0.26 2.60% |
Sino Medical Sciences fundamentals help investors to digest information that contributes to Sino Medical's financial success or failures. It also enables traders to predict the movement of Sino Stock. The fundamental analysis module provides a way to measure Sino Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sino Medical stock.
At present, Sino Medical's Gross Profit is projected to decrease significantly based on the last few years of reporting. The current year's Cost Of Revenue is expected to grow to about 170.3 M, whereas Tax Provision is projected to grow to (20.9 M). Sino | Select Account or Indicator |
Sino Medical Sciences Company Current Valuation Analysis
Sino Medical's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Sino Medical Current Valuation | 4.15 B |
Most of Sino Medical's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sino Medical Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Sino Medical Sciences has a Current Valuation of 4.15 B. This is 71.1% lower than that of the Health Care Equipment & Supplies sector and 66.59% lower than that of the Health Care industry. The current valuation for all China stocks is 75.03% higher than that of the company.
Sino Medical Sciences Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Sino Medical's current stock value. Our valuation model uses many indicators to compare Sino Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Sino Medical competition to find correlations between indicators driving Sino Medical's intrinsic value. More Info.Sino Medical Sciences is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Sino Medical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Sino Medical's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Sino Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sino Medical's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Sino Medical could also be used in its relative valuation, which is a method of valuing Sino Medical by comparing valuation metrics of similar companies.Sino Medical is currently under evaluation in current valuation category among its peers.
Sino Fundamentals
| Return On Equity | 0.0017 | ||||
| Return On Asset | -0.0247 | ||||
| Profit Margin | 0 % | ||||
| Operating Margin | 0 % | ||||
| Current Valuation | 4.15 B | ||||
| Shares Outstanding | 413.46 M | ||||
| Shares Owned By Insiders | 33.74 % | ||||
| Shares Owned By Institutions | 9.61 % | ||||
| Price To Book | 4.94 X | ||||
| Price To Sales | 9.24 X | ||||
| Revenue | 343.26 M | ||||
| Gross Profit | 458.74 M | ||||
| EBITDA | 31.95 M | ||||
| Net Income | (49.32 M) | ||||
| Total Debt | 69.27 M | ||||
| Book Value Per Share | 2.07 X | ||||
| Cash Flow From Operations | 56.84 M | ||||
| Earnings Per Share | (0.02) X | ||||
| Target Price | 14.0 | ||||
| Beta | 0.55 | ||||
| Market Capitalization | 4.24 B | ||||
| Total Asset | 1.19 B | ||||
| Retained Earnings | (234.73 M) | ||||
| Working Capital | 192.9 M | ||||
| Net Asset | 1.19 B |
About Sino Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sino Medical Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sino Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sino Medical Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Total Revenue | 308.9 M | 246.2 M | |
| Cost Of Revenue | 162.2 M | 170.3 M |
Currently Active Assets on Macroaxis
Other Information on Investing in Sino Stock
Sino Medical financial ratios help investors to determine whether Sino Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sino with respect to the benefits of owning Sino Medical security.